Octreotide acetate

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

291 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Acromegaly	D000172	—	—	5	11	16	17	9	57
Neuroendocrine tumors	D018358	EFO_1001901	D3A.8	10	24	10	3	7	50
Liver cirrhosis	D008103	EFO_0001422	K74.0	1	3	1	4	4	11
Neoplasms	D009369	—	C80	2	5	3	2	—	11
Diarrhea	D003967	HP_0002014	R19.7	—	2	3	1	3	9
Obesity	D009765	EFO_0001073	E66.9	2	1	—	3	3	9
Hepatorenal syndrome	D006530	—	K76.7	—	4	2	1	2	7
Esophageal and gastric varices	D004932	EFO_0009545	I85	1	1	—	3	1	5
Congenital hyperinsulinism	D044903	—	—	1	1	—	1	—	3
Ascites	D001201	HP_0001541	R18	—	2	1	1	—	3

Show 9 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Carcinoid tumor	D002276	—	D3A.00	4	5	4	—	—	11
Pancreatic neoplasms	D010190	EFO_0003860	C25	1	5	1	—	1	8
Prostatic neoplasms	D011471	—	C61	1	3	1	—	—	5
Breast neoplasms	D001943	EFO_0003869	C50	—	1	2	—	2	5
Liver neoplasms	D008113	EFO_1001513	C22.0	—	2	3	—	1	5
Colorectal neoplasms	D015179	—	—	—	1	4	—	—	5
Autosomal dominant polycystic kidney	D016891	EFO_1001496	Q61.2	—	2	3	—	1	5
Gastro-enteropancreatic neuroendocrine tumor	—	—	—	1	—	3	—	—	4
Diabetic retinopathy	D003930	EFO_0003770	—	—	—	4	—	—	4
Prader-willi syndrome	D011218	Orphanet_739	Q87.11	—	—	1	—	2	3

Show 20 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Neuroendocrine carcinoma	D018278	—	—	1	6	—	—	—	7
Neuroblastoma	D009447	EFO_0000621	—	3	6	—	—	—	7
Meningioma	D008579	EFO_0003098	D32.9	2	3	—	—	1	6
Medulloblastoma	D008527	—	—	1	4	—	—	1	5
Islet cell adenoma	D007516	EFO_0007331	D13.7	2	3	—	—	—	5
Esophageal neoplasms	D004938	—	C15	—	1	—	—	4	5
Pheochromocytoma	D010673	—	—	2	2	—	—	—	4
Stomach neoplasms	D013274	EFO_0003897	C16	—	2	—	—	2	4
Acute kidney injury	D058186	HP_0001919	N17	—	1	—	—	2	3
Paraganglioma	D010235	—	—	2	2	—	—	—	3

Show 34 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Healthy volunteers/patients	—	—	—	5	—	—	—	—	5
Insulin resistance	D007333	HP_0000855	E88.819	3	—	—	—	2	5
Non-alcoholic fatty liver disease	D065626	EFO_0003095	K75.81	2	—	—	—	1	3
Central nervous system neoplasms	D016543	—	—	2	—	—	—	—	2
Prediabetic state	D011236	EFO_1001121	R73.03	2	—	—	—	—	2
Pure autonomic failure	D054970	—	—	1	—	—	—	—	1
Orthostatic hypotension	D007024	—	I95.1	1	—	—	—	—	1
Von hippel-lindau disease	D006623	—	Q85.83	1	—	—	—	—	1
Multiple endocrine neoplasia type 1	D018761	—	E31.21	1	—	—	—	—	1
Merkel cell carcinoma	D015266	EFO_1001471	C4A	1	—	—	—	—	1

Show 14 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Malnutrition	D044342	EFO_0008572	E40-E46	—	—	—	—	2	2
Weight loss	D015431	HP_0001824	—	—	—	—	—	2	2
Hemorrhage	D006470	MP_0001914	R58	—	—	—	—	2	2
Hiv infections	D015658	EFO_0000764	B20	—	—	—	—	2	2
Myocarditis	D009205	—	I51.4	—	—	—	—	1	1
Brain neoplasms	D001932	EFO_0003833	C71	—	—	—	—	1	1
Glioblastoma	D005909	EFO_0000515	—	—	—	—	—	1	1
Glioma	D005910	EFO_0000520	—	—	—	—	—	1	1
Gliosarcoma	D018316	—	—	—	—	—	—	1	1
Acoustic neuroma	D009464	HP_0009588	—	—	—	—	—	1	1